Evidence map›Paper›PMID 33533401›Full record

ArticleSchizophrenia bulletin2021

A Network of Psychopathological, Cognitive, and Motor Symptoms in Schizophrenia Spectrum Disorders.

Bernardo Melo Moura, Geeske van Rooijen, Frederike Schirmbeck, Hanneke Wigman, Luís Madeira, Peter van Harten, Jim van Os, P Roberto Bakker, Machteld Marcelis, Genetic Risk and Outcome of Psychosis (GROUP) investigators

Erratum issuedAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Bernardo Melo MouraDepartment of Psychiatry, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Geeske van RooijenDepartment of Psychiatry, Academic Medical Center, University of Amsterdam, AZ Amsterdam, The Netherlands.
Frederike SchirmbeckDepartment of Psychiatry, Academic Medical Center, University of Amsterdam, AZ Amsterdam, The Netherlands.
Hanneke WigmanInterdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, University of Groningen, GZ Groningen, The Netherlands.
Luís MadeiraDepartment of Psychiatry, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Peter van HartenDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht University, MD Maastricht, The Netherlands.
Jim van OsDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht University, MD Maastricht, The Netherlands.
P Roberto BakkerDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht University, MD Maastricht, The Netherlands.
Machteld MarcelisDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht University, MD Maastricht, The Netherlands.
Genetic Risk and Outcome of Psychosis (GROUP) investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia spectrum disorders (SSDs) are complex syndromes involving psychopathological, cognitive, and also motor symptoms as core features. A better understanding of how these symptoms mutually impact each other could translate into diagnostic, prognostic, and, eventually, treatment advancements. The present study aimed to: (1) estimate a network model of psychopathological, cognitive, and motor symptoms in SSD; (2) detect communities and explore the connectivity and relative importance of variables within the network; and (3) explore differences in subsample networks according to remission status. A sample of 1007 patients from a multisite cohort study was included in the analysis. We estimated a network of 43 nodes, including all the items from the Positive and Negative Syndrome Scale, a cognitive assessment battery and clinical ratings of extrapyramidal symptoms. Methodologies specific to network analysis were employed to address the study's aims. The estimated network for the total sample was densely interconnected and organized into 7 communities. Nodes related to insight, abstraction capacity, attention, and suspiciousness were the main bridges between network communities. The estimated network for the subgroup of patients in remission showed a sparser density and a different structure compared to the network of nonremitted patients. In conclusion, the present study conveys a detailed characterization of the interrelations between a set of core clinical elements of SSD. These results provide potential novel clues for clinical assessment and intervention.

Indexed as

Schizophrenic PsychologyAdultCognitionCohort StudiesFemaleHumansMaleMotor DisordersSchizophreniaYoung Adultcognitionextrapyramidal symptomsnegative symptomsnetwork analysispositive symptomspsychosis

Identifiers

PMID33533401
PMCPMC8266645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.